Clinical trial
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
NCT00400205 · Emory University, Other · Terminated
Key facts
| NCT number | NCT00400205 |
|---|---|
| Title | Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil |
| Official title | Phase II Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil Chemotherapy in Squamous Cell Carcinoma of the Oral Cavity With Molecular Endpoints |
| Lead sponsor | Emory University, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Squamous Cell Carcinoma, Oral Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Cisplatin, 5-fluorouracil |
| Enrollment | 14 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Nov 16, 2006 |
| Last update posted | Nov 6, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: